The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma.

[1]  Michael A. S. Jewett,et al.  Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses , 2012, Tumor Biology.

[2]  A. Disch,et al.  Reference genes for the relative quantification of microRNAs in renal cell carcinomas and their metastases. , 2011, Analytical biochemistry.

[3]  Jörg Grigull,et al.  miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. , 2011, The Journal of urology.

[4]  G. Yousef,et al.  Translating molecular signatures of renal cell carcinoma into clinical practice. , 2011, The Journal of urology.

[5]  F. Monzon,et al.  Molecular Classification of Adult Renal Epithelial Neoplasms Using MicroRNA Expression and Virtual Karyotyping , 2011, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[6]  George M Yousef,et al.  Accurate molecular classification of kidney cancer subtypes using microRNA signature. , 2011, European urology.

[7]  C. Stephan,et al.  Metastamirs: a stepping stone towards improved cancer management , 2011, Nature Reviews Clinical Oncology.

[8]  G. Yousef,et al.  MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer , 2010, BMC medicine.

[9]  M. Michael,et al.  The VHL-dependent regulation of microRNAs in renal cancer , 2010, BMC medicine.

[10]  N. Rosenfeld,et al.  Accurate molecular classification of renal tumors using microRNA expression. , 2010, The Journal of molecular diagnostics : JMD.

[11]  George M Yousef,et al.  Personalized Medicine: Marking a New Epoch in Cancer Patient Management , 2010, Molecular Cancer Research.

[12]  O. Topolcan,et al.  Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases. , 2010, Cancer genetics and cytogenetics.

[13]  G. Yousef,et al.  Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs , 2010, Biological chemistry.

[14]  G. Yousef,et al.  Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer , 2010, British Journal of Cancer.

[15]  George M Yousef,et al.  The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma. , 2010, The Journal of urology.

[16]  H. Benjamin,et al.  Accurate Classification of Non–Small Cell Lung Carcinoma Using a Novel MicroRNA-Based Approach , 2010, Clinical Cancer Research.

[17]  G. Yousef,et al.  MicroRNAs in clinical oncology: at the crossroads between promises and problems , 2009, Journal of Clinical Pathology.

[18]  Yandan Yao,et al.  MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor , 2009, Clinical Cancer Research.

[19]  B. Delahunt,et al.  Uncommon and recently described renal carcinomas , 2009, Modern Pathology.

[20]  Gideon Rechavi,et al.  Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  G. Yousef,et al.  From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma , 2009, Molecular Cancer.

[22]  Hans Lehrach,et al.  MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy , 2009, Journal of cellular and molecular medicine.

[23]  Wei Liu,et al.  MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G. , 2008, Cancer letters.

[24]  Tongbin Li,et al.  miRecords: an integrated resource for microRNA–target interactions , 2008, Nucleic Acids Res..

[25]  Qiong Shao,et al.  MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. , 2008, RNA.

[26]  Vassilis Georgoulias,et al.  Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. , 2008, Clinical chemistry.

[27]  N. Colburn,et al.  MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene , 2008, Oncogene.

[28]  H. Allgayer,et al.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer , 2008, Oncogene.

[29]  F. Tokat,et al.  What is the role of percutaneous needle core biopsy in diagnosis of renal masses? , 2008, Urology.

[30]  Shuomin Zhu,et al.  MicroRNA-21 targets tumor suppressor genes in invasion and metastasis , 2008, Cell Research.

[31]  R. Vyzula,et al.  Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer , 2008, Oncology.

[32]  K. Ghoshal,et al.  MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. , 2007, Gastroenterology.

[33]  J. Patard,et al.  Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval. , 2007, The Journal of urology.

[34]  Shuomin Zhu,et al.  MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)* , 2007, Journal of Biological Chemistry.

[35]  M. Brunelli,et al.  Prognostic role of the histologic subtypes of renal cell carcinoma after slide revision. , 2006, European urology.

[36]  Ximing J. Yang,et al.  Classification of renal neoplasms based on molecular signatures. , 2006, The Journal of urology.

[37]  R. Silber,et al.  Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. , 2005, European urology.

[38]  Joseph Avruch,et al.  Rheb Binds and Regulates the mTOR Kinase , 2005, Current Biology.

[39]  T. Mekhail,et al.  Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[41]  J L Warren,et al.  Rising incidence of renal cell cancer in the United States. , 1999, JAMA.

[42]  E. B. Wilson.  Probable Inference, the Law of Succession, and Statistical Inference , 1927 .

[43]  F. Hamdy,et al.  Platinum Priority – Collaborative Review – Prostate Cancer MicroRNA in Prostate , Bladder , and Kidney Cancer : A Systematic Review , 2011 .

[44]  George M Yousef,et al.  Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. , 2010, Clinical biochemistry.

[45]  Ximing J. Yang,et al.  Molecular subclassification of kidney tumors and the discovery of new diagnostic markers , 2003, Oncogene.